HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

5th Edition of International Heart Congress

June 24-26, 2027 | Hybrid Event

June 24 -26, 2027 | Rome, Italy

Heart Congress 2027

John R Doty, Speaker at Heart Conferences
Keynote Presentation (In-Person)
John R Doty, Intermountain Medical Center, United States

Refinements in cardiac surgical techniques can now offer many patients preservation of their native aortic valve rather than replacement with biologic or mechanical prostheses. These operations range from isolated aortic valve repair to total aortic root replacement with valve re [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Understanding personalized & precision cardiology (PPC) focuses on customizing medical interventions based on an individual’s unique genetic profile, biomarkers, targets and personal health data. Unlike conventional cardiology, which relies on generalized treatment guid [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Catalytic Abs (catAbs) are multivalent immunoglobulins (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to provide proteolytic effects. Abs against Cardiac Myosin (CM) with proteolytic activity exhibiting [....] » Read More

Bijoy Krishna Banik, Speaker at Heart Conferences
Oral Presentation (In-Person)
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India

Introduction: Doxorubicin (DOX) is a broadly used anthracycline anticancer drug, but its therapeutic application is limited by cumulative, dose?dependent cardiotoxicity that may culminate in heart failure. Oxidative stress, mitochondrial impairment and activation of apoptotic pat [....] » Read More

Mahdi Ghasemiartiyan, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Mahdi Ghasemiartiyan, Independent Researcher, Iran (Islamic Republic of)

An imbalance in the Th1/Th2 immune response, specifically a shift towards Th1 dominance, is associated with increased risk factors for heart disease. This imbalance can be seen in conditions like coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM), where elevated Th [....] » Read More

Mancilla Sandoval Yoana Tenneth, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Mancilla Sandoval Yoana Tenneth, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico

Background In Mexico, 135,748 people died from heart disease in 2025; one of the causes is low treatmen adherence, is assessed through self-reporting, where adherence is overestimated, limiting the effectiveness of the treatment. Aim To compare self-reported treatment &n [....] » Read More

Fatima Michelle Villa Jimenez, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Fatima Michelle Villa Jimenez, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico

Background Gender differences in patients with cardiovascular diseases have been little explored; pioneering studies suggest a differential impact on variables such as quality of life. In the Mexican context, it has not been determined how wide these differences may be and the [....] » Read More

Hachichi Chaouki, Speaker at Heart Conferences
Poster Presentation (In-Person)
Hachichi Chaouki, Hospital universitaire de Ouargla Algérie, Algeria

Introduction: Cardiac autonomic neuropathy (CAN) is a common condition, the prevalence of which is underestimated in diabetic patients. Cardiovascular dysautonomia in diabetic patients has major complications, notably orthostatic hypotension, which can sometimes be disabling [....] » Read More

Hachichi Chaouki, Speaker at Heart Conferences
Poster Presentation (In-Person)
Hachichi Chaouki, Hospital universitaire de Ouargla Algérie, Algeria

Introduction: Cardiac troponins (cTn) play a key role in detecting myocardial necrosis in individuals suspected of having coronary syndrome (ACS). Newer, so-called ultra-sensitive or hypersensitive cTn assays demonstrate excellent sensitivity for diagnosing myocardial infarction [....] » Read More

Hachichi Chaouki, Speaker at Heart Conferences
Poster Presentation (In-Person)
Hachichi Chaouki, Hospital universitaire de Ouargla Algérie, Algeria

Introduction: The risk of developing peripheral artery disease (PAD) increases significantly in diabetic patients, who are also more exposed to ischemic events than the general population. This risk is independent of other risk factors, particularly smoking, which is considered a [....] » Read More

Trevor Tucker, Speaker at Cardiovascular Diseases Events
Keynote Presentation (Virtual)
Trevor Tucker, Dynamic Vascular Resolution Inc., Canada

Background: Arterial stiffness is a recognized biomarker of cardiovascular disease, traditionally quantified using carotid–femoral pulse wave velocity (cfPWV). Although cfPWV is the clinical gold standard, it is a global, path-averaged measure requiring two recording sites [....] » Read More

Thomas J Webster, Speaker at Heart Conferences
Keynote Presentation (Virtual)
Thomas J Webster, Brown University, United States

While nanomedicine has been around for several decades, new technological advances are pushing its boundaries. For example, this presentation will present an over 30 year journey of commercializing nanomaterials as implants now in over 45,000 patients to date showing no signs of [....] » Read More

Agustin Joison, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Agustin Joison, Cordoba Catholic University, Argentina

Introduction: Globally, ischemic heart disease has become one of the leading causes of disability-adjusted life years (DALYs), ranking first among adults over the age of 50. Residual risk can be classified into three main domains, residual lipid risk: persists despite LDL-C contr [....] » Read More

Syed Raza, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Syed Raza, Awali Hospital, Bahrain

Diabetes is a growing problem globally despite all advances in its management strategy. In the last decade particularly there has been a plethora of newer anti diabetic medications that have been introduced in the market. Recent trials and studies have shown promising results [....] » Read More

Watsapp